SBIR/STTR Research Award
AN AUTOMATED 2D-CAPILLARY ELECTROPHORESIS SYSTEM
Award amount
$149,800Program and phase
SBIR · Phase IAward year
2002Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SPECTRUMEDIX CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant):
For complex protein mixtures, including cell lysates, containing thousands of
proteins, 2-D gel electrophoresis separation (2D-PAGE) is the standard method
used to separate and isolate individual proteins for analysis. In addition to
being useful for identifying individual proteins, it is also used to monitor
changes in the amount of a specific protein or proteins as an indication of
the onset of cancer in tissue or how cancer growth is affected by
environmental influences or by treatment methods.
We will develop a capillary equivalent to the standard 2D-PAGE method. It will
offer several advantages compared to 2 D-PAGE, including automation,
quantitative measurement in individual proteins, dramatically decreased run
time, and reproducible size and pI measurement for protein identification. The
main innovation is a scheme that will couple capillary iso-electric focusing
(CIEF) with multicapillary capillary-gel electrophoresis (CGE) to allow
automated two-dimensional capillary-gel electrophoresis of protein samples to
be performed. In Phase I, the coupling scheme will be developed and tested. In
addition, the fluorescence detection chemistry using "on-column" detection on
the capillary array will be developed.
This will be a significant advance for the analysis of whole cell samples for
clinical and research studies of cancerous and pre-cancerous tissue.
PROPOSED COMMERCIAL APPLICATION: Many clinical and research labs involved in cancer research as well as proteomics research would benefit from the type of instrument that we are proposing to develop. Clinical labs for routine analysis would be our primary target, although a second design with more user control and flexibility for research applications would probably be the initial market.
Technology keywords
Not reported